Description: The article provides a summary of key issues presented at the 2023 U.S. Living to 100 Symposium focused on the interests of retirement professionals and retirees. It provides an overview of the subjects covered. The discussion focused on the well-being of retirees and the development of the retirement system. It is focused on late-in-life issues and having the best life possible during that period. It balances technical and lifestyle issues, with an emphasis on mortality and longevity trends and influences. Some of the topics discussed include the impact of COVID, climate, housing, and age-friendly communities. The Elder Tech Symposium was merged into Living to 100 and includes discussion of a variety of technology approaches to improve lives and simplify support. The symposium recognized that the decisions needed and concerns during retirement are different later in life, particularly as people decline.

Description: S&P reissued a second Request for Comment (RFC) in May 2023 that proposed changes to their insurer capital adequacy methodology and assumptions, and suggested these proposed changes may become effective at the end of 2023. This paper is to highlight the notable changes between the current capital model criteria and the proposed model. We also discuss major changes from the first RFC and the second RFC, as well as several key items that still require enhanced guidance and clarification. Our analysis is based on information gathered from S&P's public comments, conversations with industry participants, and publications released by S&P Global as of July 2023 when this paper was written. Most U.S. life insurers are rated by S&P using their U.S. Life Statutory Capital model, while other insurers use the GAAP/IFRS Capital Model. Statutory financials will remain the starting point for U.S. life insurers under the proposed model, however there will be additional adjustments made to these numbers in an effort to create consistency and comparability with other accounting and solvency regimes.

Description: What are Biosimilar drugs? Are they the same as generic drugs? What potential impact might Biosimilars have in the United States prescription drug landscape and it’s economics? This article explores those questions as well as exclusivity and interchangeability.

Description: View the Fall 2023 FSA Exam Book List.

Description: Read how the world’s largest provider of specialty insurance for classic vehicles uses its media department’s YouTube videos to its full advantage.

Description: View the archived syllabus/syllabi and updates for the Fall 2023 Quantitative Finance and Investment Investment Risk Management (QFIIRM) Exam.

Description: A recap of the 2023 National Fall NAIC meeting and an overview of the SOA's participation. This event provided SOA members with an opportunity to share key research and related material with insurance regulators, actuaries and other experts.

Description: A description of the changes that have been made to the pathway to FSA.

Description: As announced in May of 2022, reductions in exam hours have been made to the SOA’s Fellowship tracks. At the same time changes to some of the FSA track modules were announced. Please read more for the update regarding the FSA module transitions.

Description: Focusing on closed and open pools, hurdle rate policy, and delayed recognition of gains and losses, the report contributes to ongoing discussions and paves the way for informed decision-making in the implementation of lifetime pension pools.